The Hill: Serving the poor is what we do

Every day, the 340B drug discount program helps providers that treat the underserved across America and it’s more essential than ever. Yet the pharmaceutical industry has attacked hospitals for somehow ...

Becker’s Healthcare: Halting 340B funding would force 73% of hospitals to cut staff, study finds

If the 340B Drug Pricing Program were restricted or no longer available, safety-net hospitals would face a myriad of challenges, according to a recent study by 340B Health. Signed into ...

The Hill: When drug prices threaten patient care

The debate over high drug prices has raged for decades, thanks to the inherent tension between delivering innovative and cost-effective patient care. But recently something has changed, and it’s one ...

Value Walk: How To Boost Drug Companies’ Profits Without Hurting Poor Americans

A Free Market Reform that Can Help Everybody Drug companies, like all for-profit companies, are all about profits. Their basic job is to take investors’ money and use it to ...

Modern Healthcare: Commentary: Guidance on 340B drug program delivers mismatch of policy, priorities from HHS

The Obama administration and HHS Secretary Sylvia Mathews Burwell have admirable goals for our nation’s healthcare system: greater provider collaboration; prevention and keeping people well after a hospital visit; payments ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields